Lecanemab Offers Hope for Early Alzheimer's | Toronto News

A Canadian hospital is now offering lecanemab, a groundbreaking infusion therapy for early-stage Alzheimer’s, designed to slow cognitive decline and help patients preserve memories for years. Clinical trials show many patients avoid advancing to severe stages over four years, offering real hope—like Barry, who’s starting treatment with optimism for five to ten more years of mental clarity. Infusions occur every two weeks, initially in hospitals with future plans for community access, accompanied by rigorous monitoring. With dementia cases in Peel projected to triple by 2050, this treatment is vital for early-stage patients only—though it’s not a cure and costs are currently out of pocket, requiring a doctor’s referral to a memory clinic. Listen in comfort:Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn. Advertise on DNN:[email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected]. View sources & latest updates:https://sources.thednn.ai/0e9ebc5e73b3408a